Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111822103 | 11182210 | 3 | F | 20150327 | 20160706 | 20150611 | 20160712 | EXP | DE-ACTELION-A-US2015-119414 | ACTELION | 65.00 | YR | E | F | Y | 0.00000 | 20160712 | OT | DE | NL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111822103 | 11182210 | 1 | PS | VENTAVIS | ILOPROST | 1 | Respiratory (inhalation) | 5 MCG, 6 TIMES DAILY | U | U | 21779 | 5 | UG | INHALATION VAPOUR, SOLUTION | |||||
| 111822103 | 11182210 | 2 | SS | VENTAVIS | ILOPROST | 1 | Respiratory (inhalation) | UNK, TID | U | U | 21779 | INHALATION VAPOUR, SOLUTION | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 111822103 | 11182210 | 1 | Pulmonary arterial hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 111822103 | 11182210 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 111822103 | 11182210 | Haemoglobin decreased | |
| 111822103 | 11182210 | Headache | |
| 111822103 | 11182210 | Hypotension | |
| 111822103 | 11182210 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 111822103 | 11182210 | 1 | 20141014 | 0 |